Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Obstet Gynecol. 2012 Mar;119(3):582–589. doi: 10.1097/AOG.0b013e318244ee3d

Table 4.

Correlates of Any Vaginal Pap Abnormality Among HIV Seropositive Women

Characteristic Odds Ratio 95% Lower Confidence Limit* 95% Upper Confidence Limit P
CD4 Greater than 500 (ref) 1 <.001
200–500 1.80 1.30 2.47 0.003
Less than 200 3.06 1.96 4.76 <.001
HIV RNA level (copies/μl) Less than or equal to 4000 (ref) 1 0.02
4001–20,000 1.33 0.99 1.78 0.06
20,001–100,000 1.40 1.00 1.96 0.0496
Greater than 100,000 1.68 1.07 2.65 0.02
Smoking Never (ref) 1
Former 1.73 0.91 3.28 0.09
Current 2.52 1.35 4.70 0.004
HAART use in past 6 mo No (ref) 1
Yes 1.94 1.45 2.59 <.0001

HIV, human immunodeficiency virus; HAART, highly active antiretroviral therapy.

*

Confidence limit

P for trend.